Registration of 'Julie' High beta-Glucan Spring Barley

The numerous health benefits associated with the consumption of barley has resulted in U. S. Food and Drug Administration approval for the use of high beta-glucan barley in reducing the risk of cardiovascular disease. With the objective of releasing high-value food barley to meet that health claim, 'Julie' (Reg. No. CV-351, PI 665006), a two-rowed, spring, high beta-glucan barley (Hordeum vulgare L.) was developed and submitted for release in 2009 by the USDA-ARS, Aberdeen, ID, in cooperation with the University of Idaho Agricultural Experiment Station. Julie is a selection from the cross 10/'Azhul'//'CDC Alamo'. 10 is a selection from composite cross XXXII made by Dr. Tom Ramage (USDA-ARS, retired). Azhul is a six-rowed, high beta-glucan cultivar released by the USDA-ARS and the Arizona Agricultural Experiment Station and is the progenitor of most high beta-glucan cultivars and germplasm. Azhul was developed by the mutation of line 76-19-7 with diethyl sulfate. Line 76-19-7 has the pedigree CCXXXII/'Arimont'//'Westbar'. CDC Alamo, tested as HB340, has the pedigree SB85750/Azhul. Under dryland and irrigated conditions, the yield and test weight of Julie are greater than those of the currently grown high beta-glucan varieties CDC Alamo and Azhul, and Julie has a higher yield of barley beta-glucan on a per hectare basis.